Bank Julius Baer & Co. A.G., Guernsey Branch Share Price

Certificat

SBKEJB

CH1239729184

Real-time Bid/Ask 11:26:33 26/06/2024 BST
102.9 CHF / 103.4 CHF +0.73% Intraday chart for Bank Julius Baer & Co. A.G., Guernsey Branch
Current month+3.23%
1 month+3.91%
Date Price Change
24/06/24 102.4 +1.79%
21/06/24 100.6 +0.10%
20/06/24 100.5 +0.20%
19/06/24 100.3 +0.55%
18/06/24 99.75 -0.45%

Delayed Quote Swiss Exchange

Last update June 24, 2024 at 04:20 pm

More quotes

Static data

Product typeBonus- und Teilschutz-Zertifikate
Buy / SellCALL
Underlying NOVARTIS AG
Issuer Bank Julius Bär
SBKEJB
ISINCH1239729184
Date issued 31/01/2023
Strike 82.46 CHF
Maturity 31/07/2024 (36 Days)
Parity 1 : 1
Emission price 82.46 CHF
Emission volume N/A
Settlement Beides
Currency CHF

Technical Indicators

Highest since issue 102.4 CHF
Lowest since issue 77.4 CHF
Spread 0.5 CHF
Spread %0.48%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.2 USD
Average target price
110.3 USD
Spread / Average Target
+2.88%
Consensus
  1. Stock Market
  2. Certificates
  3. SBKEJB Certificat